Iodide

Iodide

SCHEMBL4173002

Cc1cc(C)cc(NC(=O)N2CC[N+](C)(C)CC2)c1.[I-]

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.51
NPC1 O15118 2/20 0.51
MAPT P10636 2/20 0.51
ALDH1A1 P00352 1/20 0.50
THRB P10828 1/20 0.49
LMNA P02545 3/20 0.47
USP2 O75604 1/20 0.47
TSHR P16473 1/20 0.47
AADAT Q8N5Z0 1/20 0.46
POLB P06746 2/20 0.45
GOT1 P17174 1/20 0.45
GAA P10253 1/20 0.45
NPSR1 Q6W5P4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL4152051 0.83 MAPT (0.48) RAB9ANPC1MAPTALDH1A1THRB
Iodide SCHEMBL4155962 0.83 NPSR1 (0.67) RAB9ANPC1MAPTALDH1A1LMNA
Iodide SCHEMBL4155309 0.83 CACNA1H (0.47) MAPTALDH1A1USP2POLBNPSR1
Iodide SCHEMBL4157680 0.81 MAPT (0.46) RAB9ANPC1MAPTALDH1A1THRB
SCHEMBL4301473 0.79 KDM4E (0.59) RAB9ANPC1MAPTALDH1A1THRB
Hydrochloric Acid SCHEMBL28953557 0.79 RAB9A (0.69) RAB9ANPC1MAPTALDH1A1LMNA
Iodide SCHEMBL4154030 0.79 NPSR1 (0.68) RAB9ANPC1MAPTALDH1A1POLB
SCHEMBL30576750 0.78 POLB (0.59) RAB9ANPC1MAPTALDH1A1THRB
Iodide SCHEMBL4166734 0.76 CYP2D6 (0.65) NPC1MAPTALDH1A1USP2TSHR
Iodide SCHEMBL4162697 0.76 TRPV1 (0.57) RAB9ANPC1MAPTALDH1A1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090118303-A1 SEROTONIN 5-HT3 RECEPTOR AGONIST RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2009-05-07 US disclosed
US-7485646-B2 Serotonin 5-HT3 receptor agonist RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2009-02-03 US disclosed
US-20070265277-A1 Serotonin 5-Ht3 Receptor Agonist RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2007-11-15 US disclosed
EP-1798227-A1 SEROTONIN 5-HT3 RECEPTOR AGONIST Research Foundation Itsuu Laboratory (JP) 2007-06-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118303-A1 SEROTONIN 5-HT3 RECEPTOR AGONIST HTR3A, HTR7, HTR1A RAB9A 849/4885NPC1 3926/4885MAPT 4268/4885
US-20070265277-A1 Serotonin 5-Ht3 Receptor Agonist HTR3A, HTR7, HTR1A RAB9A 849/4885NPC1 3926/4885MAPT 4268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.